Nicolas Moitessier is Professor of Chemistry at McGill University and co-founder and CSO of Molecular Forecaster. His research interests lie at the interface of computational chemistry and medicinal chemistry including software development, machine learning, development of quantum mechanical techniques but also organic and asymmetric synthesis, medicinal chemistry and biochemistry. A major focus of his research team is on covalent drugs including prolyloligopeptidase and fibroblast activation protein alpha inhibitors as potential Parkinson’s disease and cancer therapeutics.